Thursday, March 05, 2015 2:21:04 PM
the s-1 is for everything that kim needs money for...and i didnt say vietnam had nothing to do with the s-1...i said it is not something that would hold up the s-1 nor does it need to detailed in the s-1...just included as a added potential need for the shares...
"If he was not waiting because there was no viet nam deal THEN he would be stalling while trying to figure out what to do. "
currently, there IS no deal...not until vietnam enacts new laws or changes its mind..and kim IS stalling trying to figure out what to do...
"So we use the word "stalling" so that it is a bad thing he is doing intentionally to the shareholders."
the stalling IS intentional...he is not "doing it to" the shareholders...he is doing it because without vietnam, hes got nothing...
"After all you and all the shareholders are WAITING right? Or would you say you are stalling? "
waiting for the s-1 that kim is buying time with...correct...
how on earth could shareholders be "stalling"...lol
"If Kim is waiting then he is in the same boat as all of us. That isnt a bad thing..... cant point at that."
if it makes anyone feel better that the ceo and shareholders are in the same boat going nowhere, wonderful...
but i dont see comfort in that...
kim can get the s-1 approved anytime he chooses too...but he is stalling...
its that simple
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM